Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by HY-1016 Sustain-released Injection

· Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by HY-1016 Sustain-released Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis